市場調查報告書

Buprenorphine市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Buprenorphine Market, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968780
出版日期 內容資訊 英文 183 Pages
商品交期: 2-3個工作天內
價格
Buprenorphine市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年 Buprenorphine Market, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年10月13日內容資訊: 英文 183 Pages
簡介

Buprenorphine是一種合成的阿片類生物鹼硫胺素衍生物,效力比嗎啡高約25-40倍。慢性疼痛的患病率和創傷增加是丁丙諾芬市場增長的關鍵因素。

本報告提供全球Buprenorphine市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場範圍

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 償付方案
  • 流行病學
  • PEST分析
  • 法規方案
  • 新產品銷售
  • 聯盟·契約
  • 市場趨勢

第4章 全球Buprenorphine市場:COVID-19疫情的影響

  • COVID-19市場方案
  • COVID-19對Buprenorphine產品市場的影響

第5章 全球Buprenorphine市場:各適應症

  • 簡介
  • 止痛藥
  • 類鴉片物質拮抗劑

第6章 全球Buprenorphine市場:各給藥途徑

  • 簡介
  • 注射
  • 舌下
  • 經皮吸收貼片

第7章 全球Buprenorphine市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第8章 全球Buprenorphine市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Siegfried
    • Sanofi
    • Johnson Matthey
    • Mallinckrodt
    • Noramco
    • Unichem Laboratories
    • Arevipharma GmbH
    • Resonance-labs
    • Sun Pharmaceutical Industries Ltd.
    • Rusan Pharma
    • Micro Orgo Chem
    • Faran Shimi Pharmaceutical Co.
    • 分析師的見解

第10章 章節

目錄

Title:
Buprenorphine Market, by Application (Analgesic and Opioid Antagonist), by Route of Administration (Injectables, Sublingual, and Transdermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Buprenorphine is a synthetic opioid alkaloid thiamine derivative with around 25- 40 times more potency than morphine. It acts primarily on the central nervous system and indicated for treatment of moderate to severe pain, peri-operative analgesia and opioid dependence. It is marketed in various dosage forms such as injectables, sublingual tablets & spray, transdermal patches.

Market Dynamics

Increasing prevalence of chronic pain, trauma injuries is a major factor driving buprenorphine market growth. According to the National Health Interview Survey (NHIS) 2016, an estimated 50 million of the U.S. adults suffered with chronic pain and around 19.6 million has high impact of chronic pain. Moreover, government initiatives for combatting problem of substance dependency and drug abuse is expected to boost the market growth. For instance, in April 2013, the Republic of Philippines under the President Rodrigo Roa Duterte, designed anti-drug cleansing efforts in cooperation with government and non-government agencies.

However, lack of licensed physicians for prescribing buprenorphine can hinder the market growth. According to the American Journal of Preventive Medicine, in June 2018, less than 4% licensed physicians were approved to prescribe buprenorphine for opioid use disorder.

Key features of the study:

  • This report provides in-depth analysis of the global buprenorphine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global buprenorphine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global buprenorphine market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global buprenorphine market.

Detailed Segmentation:

  • Global Buprenorphine Market, By Application:
    • Analgesic
    • Opioid Antagonist
  • Global Buprenorphine Market, By Route of Administration:
    • Injectables
    • Sublingual
    • Transdermal Patches
  • Global Buprenorphine Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Buprenorphine Market, By Region:
    • North America
      • By Application:
      • Analgesic
      • Opioid Antagonist
      • By Route of Administration
      • Injectables
      • Sublingual
      • Transdermal Patches
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Application:
      • Analgesic
      • Opioid Antagonist
      • By Route of Administration
      • Injectables
      • Sublingual
      • Transdermal Patches
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Application:
      • Analgesic
      • Opioid Antagonist
      • By Route of Administration
      • Injectables
      • Sublingual
      • Transdermal Patches
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Application:
      • Analgesic
      • Opioid Antagonist
      • By Route of Administration
      • Injectables
      • Sublingual
      • Transdermal Patches
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Application:
      • Analgesic
      • Opioid Antagonist
      • By Route of Administration
      • Injectables
      • Sublingual
      • Transdermal Patches
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Application:
      • Analgesic
      • Opioid Antagonist
      • By Route of Administration
      • Injectables
      • Sublingual
      • Transdermal Patches
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Siegfried*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sanofi
    • Johnson Matthey
    • Mallinckrodt
    • Noramco
    • Unichem Laboratories
    • Arevipharma GmbH
    • Resonance-labs
    • Sun Pharmaceutical Industries Ltd.
    • Rusan Pharma
    • Micro Orgo Chem
    • Faran Shimi Pharmaceutical Co.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Application
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Buprenorphine Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Buprenorphine Products

5. Global Buprenorphine Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Analgesic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Opioid Antagonist
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Buprenorphine Market, By Route of Administration, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Injectables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Transdermal Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Buprenorphine Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Buprenorphine Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Siegfried
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson Matthey
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mallinckrodt
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Noramco
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Unichem Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Arevipharma GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Resonance-labs
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rusan Pharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Micro Orgo Chem
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Faran Shimi Pharmaceutical Co.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact